Talk:Arbutus Biopharma
Latest comment: 6 years ago by 68.0.86.218 in topic Update Request
![]() | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||||||
|
![]() | The contents of the Arbutus Biopharma page were merged into TKM-Ebola. For the contribution history and old versions of the merged article please see its history. |
Update Request
editRoivant recently invested in Arbutus' hepatitis B program. Can you update the page to include information on the program/investment? [1] [2] [3] 68.0.86.218 (talk) 15:04, 8 November 2017 (UTC)
References
- ^ https://www.fiercebiotech.com/biotech/ramaswamy-s-roivant-backs-arbutus-hepatitis-b-program
- ^ http://roivant.com/arbutus-receive-116-million-strategic-investment-roivant-sciences/
- ^ https://www.forbes.com/sites/nathanvardi/2017/10/02/roivant-makes-116-million-investment-in-arbutus-backing-battle-with-moderna/#30896a865e20